Showing results (21-30 of 62) with videos related to

Sort By:
Pageof 7
Molecular Imaging and Biology|September 25, 2010
Correlation between epidermal growth factor receptor-specific nanobody uptake and tumor burden: a tool for noninvasive monitoring of tumor response to therapyLea Olive Tchouate Gainkam, Marleen Keyaerts, Vicky Caveliers, et al.
Theranostics|November 8, 2019
Theranostics in immuno-oncology using nanobody derivativesQuentin Lecocq, Yannick De Vlaeminck, Heleen Hanssens, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 15, 2013
Synthesis, preclinical validation, dosimetry, and toxicity of 68Ga-NOTA-anti-HER2 Nanobodies for iPET imaging of HER2 receptor expression in cancerCatarina Xavier, Ilse Vaneycken, Matthias D'huyvetter, et al.
Oncotarget|April 15, 2017
Non-invasive assessment of murine PD-L1 levels in syngeneic tumor models by nuclear imaging with nanobody tracersKatrijn Broos, Marleen Keyaerts, Quentin Lecocq, et al.
Biomolecules|October 2, 2019
Noninvasive Imaging of the Immune Checkpoint LAG-3 Using Nanobodies, from Development to Pre-Clinical UseQuentin Lecocq, Katty Zeven, Yannick De Vlaeminck, et al.
Molecular Imaging and Biology|February 26, 2008
SPECT imaging with 99mTc-labeled EGFR-specific nanobody for in vivo monitoring of EGFR expressionLieven Huang, Lea Olive Tchouate Gainkam, Vicky Caveliers, et al.
Pharmaceuticals (Basel, Switzerland)|July 2, 2021
Site-Specific Radiolabeling of a Human PD-L1 Nanobody via Maleimide-Cysteine ChemistryDora Mugoli Chigoho, Quentin Lecocq, Robin Maximilian Awad, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 24, 2007
123I-2-iodo-tyrosine, a new tumour imaging agent: human biodistribution, dosimetry and initial clinical evaluation in glioma patientsMarleen Keyaerts, Tony Lahoutte, Bart Neyns, et al.
Pageof 7